Investment Column: Complacency is dangerous for Homeserve

BSS; Torotrak


Our view: Hold

Share price: 1909p (+1p)

Hard to see much to dislike about results from Homeserve, whose machine appears unlikely to need the sort of repair work its customers call on it to perform anytime soon. Offering insurance against a range of household glitches, and then dealing with problems quickly when they arise, has proved to be a highly successful formula. Just how successful was illustrated by yesterday's results for the year ending 31 March. Revenue grew 21 per cent to £369m, profits 27 per cent to £102.2m, and the dividend was hiked by 24 per cent.

So happy days, then. And there could be much more to come. British companies sometimes have trouble replicating business models that have proved successful in their home market when they attempt to take them overseas. But so far the signs from Homeserve's overseas operations appear to be positive. Homeserve has said that there is good potential for the business in the US, and this appears to be being crystallised.

We've been holders of Homeserve since last September, when the shares stood at 1542p. So those who followed our advice have done well. Should we have been buyers and should we buy now? That's another question.

Homeserve's shares are not cheap, trading on nearly 16 times Panmure's estimates for the full year. We also worry a little about how sustainable its business model is. As companies get bigger they can often get lazy and complacent. That is particularly true of the insurance sector, as too many who have had the misfortune of calling on it when it gets to claim time can testify. We're not saying that is true of Homeserve, but its product is not an essential purchase, and its reputation could be in danger if it ever takes its eye off the ball. It isn't necessarily the case that this will happen. But it is a risk. That said, the performance so far has been impressive. We wouldn't blame anyone for taking profits, but for now, we'd still hold the shares.

BSS

Our view: Buy

Share price: 320p (+8.5p)

BSS, the plumbing and heating group which issued full-year figures yesterday, closed over 2 per cent higher last night, which doesn't sound like much but was actually rather impressive given that the FTSE 250 fell by a hefty 3.1 per cent. Its trading update, which brought news of pre-tax profits at the top end of market expectations, clearly pleased investors, confirming both a creditable performance in the year gone by and a strong start to 2010. BSS also used yesterday's results to answer worries about the impact of the coalition's austerity drive by highlighting the fact that only around 10 per cent of its revenues flow from areas where the Government's cuts could be an issue. The vast majority of revenues, it said, are "not reliant on government capital expenditure".

So is it time to buy? There are two views. BSS is certainly not expensive: the stock trades on a multiple of 10.8 times Panmure Gordon's estimates for the full year. But some reckon that it may be fairly valued. BSS is up nearly 30 per cent since the beginning of the year, while the wider sector is slightly down. In response, we'd point out that the multiple falls to less than 10 when you factor in Panmure's estimates for 2011. Investors generally are increasingly risk-averse, and they're itching for safe havens. BSS, in our view, is among the safest plays in its sector. That should ensure strength as market volatility continues. Buy.

Torotrak

Our view: Avoid

Share price: 20.5p (-2.5p)

Torotrak is a tricky call. The company owns more than 400 patents relating to hi-tech transmission systems that can be used both in all sorts of vehicles and also in auxiliary drives such as super-chargers or kinetic energy recovery (KER) systems. Sounds incomprehensible, but it could be really big. Efficient transmission and super-chargers both boost engine performance – a major plus in these carbon-conscious times. And KERs capture and re-use braking energy – also increasingly popular.

After management changes five years ago, Torotrak has made progress. It is in production in the US lawn mower market. And it has two prototypes under development, one under licence to an unnamed "major European bus and truck manufacturer", the other to world-leading Allison Transmission. Preliminary results published yesterday show improvements, with revenues up 65 per cent to £7.6m and an operating profit of £100,000, compared to last year's £2.4m loss. But there are risks.

The big decision from Allison won't be made until the second quarter of 2011. Until then, there are not really any clear earnings estimates. In another year, Torotrak may be worth a punt. Maybe. But until then, avoid.

Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
Attenborough with the primates
tvWhy BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter
News
Campbell: ‘Sometimes you have to be economical with the truth’
newsFormer spin doctor says MPs should study tactics of leading sports figures like José Mourinho
Sport
football
Life and Style
Agretti is often compared to its relative, samphire, though is closer in taste to spinach
food + drink
News
Kelly Osbourne will play a flight attendant in Sharknado 2
people
News
Down-to-earth: Winstone isn't one for considering his 'legacy'
people
News
The dress can be seen in different colours
i100
Sport
Wes Brown is sent-off
football
Voices
Lance Corporal Joshua Leakey VC
voicesBeware of imitations, but the words of the soldier awarded the Victoria Cross were the real thing, says DJ Taylor
Life and Style
Alexander McQueen's AW 2009/10 collection during Paris Fashion Week
fashionMeet the collaborators who helped create the late designer’s notorious spectacles
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: HR Benefits Manager

£40000 - £50000 per annum + pro rata: SThree: SThree Group have been well esta...

Recruitment Genius: Office Manager / Financial Services

£30000 - £37000 per annum: Recruitment Genius: Established in 1999, a highly r...

Jemma Gent: Year End Accountant

£250-£300 Day Rate: Jemma Gent: Are you a qualified accountant with strong exp...

Jemma Gent: Management Accountant

£230 - £260 Day Rate: Jemma Gent: Do you want to stamp your footprint in histo...

Day In a Page

War with Isis: Fears that the looming battle for Mosul will unleash 'a million refugees'

The battle for Mosul will unleash 'a million refugees'

Aid agencies prepare for vast exodus following planned Iraqi offensive against the Isis-held city, reports Patrick Cockburn
Yvette Cooper: We can't lose the election. There's too much on the line

Yvette Cooper: We can't lose the election. There's too much on the line

The shadow Home Secretary on fighting radical Islam, protecting children, and why anyone in Labour who's thinking beyond May must 'sort themselves out'
A bad week for the Greens: Leader Natalie Bennett's 'car crash' radio interview is followed by Brighton council's failure to set a budget due to infighting

It's not easy being Green

After a bad week in which its leader had a public meltdown and its only city council couldn't agree on a budget vote, what next for the alternative party? It's over to Caroline Lucas to find out
Gorillas nearly missed: BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter

Gorillas nearly missed

BBC producers didn't want to broadcast Sir David Attenborough's famed Rwandan encounter
Downton Abbey effect sees impoverished Italian nobles inspired to open their doors to paying guests for up to €650 a night

The Downton Abbey effect

Impoverished Italian nobles are opening their doors to paying guests, inspired by the TV drama
China's wild panda numbers have increased by 17% since 2003, new census reveals

China's wild panda numbers on the up

New census reveals 17% since 2003
Barbara Woodward: Britain's first female ambassador to China intends to forge strong links with the growing economic superpower

Our woman in Beijing builds a new relationship

Britain's first female ambassador to China intends to forge strong links with growing economic power
Courage is rare. True humility is even rarer. But the only British soldier to be awarded the Victoria Cross in Afghanistan has both

Courage is rare. True humility is even rarer

Beware of imitations, but the words of the soldier awarded the Victoria Cross were the real thing, says DJ Taylor
Alexander McQueen: The catwalk was a stage for the designer's astonishing and troubling vision

Alexander McQueen's astonishing vision

Ahead of a major retrospective, Alexander Fury talks to the collaborators who helped create the late designer's notorious spectacle
New BBC series savours half a century of food in Britain, from Vesta curries to nouvelle cuisine

Dinner through the decades

A new BBC series challenged Brandon Robshaw and his family to eat their way from the 1950s to the 1990s
Philippa Perry interview: The psychotherapist on McDonald's, fancy specs and meeting Grayson Perry on an evening course

Philippa Perry interview

The psychotherapist on McDonald's, fancy specs and meeting Grayson Perry on an evening course
Bill Granger recipes: Our chef recreates the exoticism of the Indonesian stir-fry

Bill Granger's Indonesian stir-fry recipes

Our chef was inspired by the south-east Asian cuisine he encountered as a teenager
Chelsea vs Tottenham: Harry Kane was at Wembley to see Spurs beat the Blues and win the Capital One Cup - now he's their great hope

Harry Kane interview

The striker was at Wembley to see Spurs beat the Blues and win the Capital One Cup - now he's their great hope
The Last Word: For the good of the game: why on earth don’t we leave Fifa?

Michael Calvin's Last Word

For the good of the game: why on earth don’t we leave Fifa?
HIV pill: Scientists hail discovery of 'game-changer' that cuts the risk of infection among gay men by 86%

Scientists hail daily pill that protects against HIV infection

Breakthrough in battle against global scourge – but will the NHS pay for it?